12:00 AM
Aug 21, 2000
 |  BC Week In Review  |  Company News  |  Deals

Neurobiological, University of California deal

NTII signed an option to negotiate an exclusive license with the university for patents covering corticotropin-releasing hormone (CRH) analogs. The agreement also includes a work plan...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >